All stock lists
American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
Real Estate · REIT - Healthcare Facilities
53.14+0.12 (+0.23%)
Insider Score
––Not scored
AHR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AHR analyst forecast
AHR analyst consensus
Moderate Buy8 ratings
Buy 8 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
AHR 12-month price target
$64.00+20.4% upsideaverage of 2 firms
$66.00High
$62.00Low
Best analysts covering AHR
- Truist Securities100%success rate · 10 calls
- Keybanc100%success rate · 5 calls
- Morgan Stanley100%success rate · 4 calls
- RBC Capital100%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AHR analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | UBS | Buy | — | — | Reiterated | 2026-10-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-13 |
| Scotiabank | Sector Outperform | $62.00 | +11.1% | Reiterated | 2026-09-02 | |
| Barclays | Overweight | $66.00 | +18.9% | Reiterated | 2026-08-31 | |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-08-19 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-14 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-14 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-08-13 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-07-27 |
| — | UBS | Buy | — | — | Reiterated | 2026-07-08 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-07-07 |
| — | Citigroup | Buy | — | — | Upgraded | 2026-06-23 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2026-06-18 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-05-28 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-05-26 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-03-13 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2026-03-11 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-03-02 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-02-05 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-01-20 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-11-26 |
| — | Citigroup | Neutral | — | — | Reiterated | 2025-11-21 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-11-20 |
| — | UBS | Buy | — | — | Reiterated | 2025-11-17 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-11-13 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-11-13 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-11-12 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2025-11-10 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-10-17 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-10-14 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-08-28 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-08-26 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-08-18 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-08-13 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-08-11 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-06-11 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-06-09 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-05-20 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-03-31 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-03-25 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-03-19 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-03-18 |
| — | Citizens Capital Markets | Market Outperform | — | — | Reiterated | 2025-03-04 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-12-30 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-11-18 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-11-15 |
| — | B of A Securities | Buy | — | — | Reiterated | 2024-09-24 |
| — | Keybanc | Overweight | — | — | Reiterated | 2024-09-20 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-09-20 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-09-20 |
| — | Keybanc | Overweight | — | — | Reiterated | 2024-09-16 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-09-03 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-08-22 |
| — | B of A Securities | Buy | — | — | Reiterated | 2024-08-20 |
| — | B of A Securities | Buy | — | — | Reiterated | 2024-08-08 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-08-07 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-07-01 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-05-16 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-04-03 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-03-25 |
AHR earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-26 | 0.15 | 0.06 | $609.5M | $604.1M |
| 2026-05-07 | 0.16 | 0.13 | $667.6M | $650.8M |
| 2026-08-06 | 0.14 | 0.16 | $645.3M | $671.0M |
| 2026-11-05 | 0.15 | 0.00 | $703.5M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.